Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L SMITH

Showing results (391-400 of 409) with videos related to

Pageof 41
Sort By:
Cancer|February 1, 1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trialA U Buzdar, G R Blumenschein, T L Smith, et al.
Breast Cancer Research and Treatment|November 6, 2004
Expression of sigma 1 receptor in human breast cancerB Wang, R Rouzier, C T Albarracin, et al.
Cancer|August 1, 1991
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosisA A Sahin, J Ro, J Y Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
The New England Journal of Medicine|February 18, 1999
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working GroupT L Smith, M L Pearson, K R Wilcox, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteriaC S Ha, V Kavadi, M A Dimopoulos, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Archives of Internal Medicine|September 1, 1978
Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicinC A Coltman, G P Bodey, J S Hewlett, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
JAMA|October 5, 1979
Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up reportA U Buzdar, G R Blumenschein, J U Gutterman, et al.
Pageof 41

Showing results (391-400 of 409) with videos related to

Sort By:
Pageof 41
Cancer|February 1, 1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trialA U Buzdar, G R Blumenschein, T L Smith, et al.
Breast Cancer Research and Treatment|November 6, 2004
Expression of sigma 1 receptor in human breast cancerB Wang, R Rouzier, C T Albarracin, et al.
Cancer|August 1, 1991
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosisA A Sahin, J Ro, J Y Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
The New England Journal of Medicine|February 18, 1999
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working GroupT L Smith, M L Pearson, K R Wilcox, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteriaC S Ha, V Kavadi, M A Dimopoulos, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Archives of Internal Medicine|September 1, 1978
Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicinC A Coltman, G P Bodey, J S Hewlett, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
JAMA|October 5, 1979
Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up reportA U Buzdar, G R Blumenschein, J U Gutterman, et al.
Pageof 41